Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort. / Bjerrum, Andreas; Andersen, Ole; Fischer, Anders; Lindebjerg, Jan; Lynge, Elsebeth.

In: International Journal of Cancer, Vol. 141, No. 3, 01.08.2017, p. 503-511.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bjerrum, A, Andersen, O, Fischer, A, Lindebjerg, J & Lynge, E 2017, 'Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort', International Journal of Cancer, vol. 141, no. 3, pp. 503-511. https://doi.org/10.1002/ijc.30756

APA

Bjerrum, A., Andersen, O., Fischer, A., Lindebjerg, J., & Lynge, E. (2017). Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort. International Journal of Cancer, 141(3), 503-511. https://doi.org/10.1002/ijc.30756

Vancouver

Bjerrum A, Andersen O, Fischer A, Lindebjerg J, Lynge E. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort. International Journal of Cancer. 2017 Aug 1;141(3):503-511. https://doi.org/10.1002/ijc.30756

Author

Bjerrum, Andreas ; Andersen, Ole ; Fischer, Anders ; Lindebjerg, Jan ; Lynge, Elsebeth. / Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort. In: International Journal of Cancer. 2017 ; Vol. 141, No. 3. pp. 503-511.

Bibtex

@article{efb2a854da1843adadc812735a1e8047,
title = "Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort",
abstract = "Faecal occult blood test (FOBT) screening for colorectal cancer (CRC) is implemented in several countries. Approximately half of all screen positive persons have negative colonoscopy, but consensus is lacking on how these persons should be followed up. Health authorities in Denmark and The Netherlands recommend suspending screening for 8–10 years, while patients in UK are invited to screening after 2 years. In this cohort-study, we followed 166,277 individuals invited to FOBT-screening in 2005–2006 and a reference group comprising the remaining 1,240,348 Danes of the same age. We linked Danish population and health service registers to obtain information about colonoscopy outcome and incident CRC. We estimated CRC risk by colonoscopy outcome (adenoma, other colorectal pathology or negative colonoscopy) for the reference group, the screening group, and subgroups. Persons with positive screening FOBT followed by negative colonoscopy had the same long-term CRC risk as persons with adenoma detected due to a positive screening FOBT (aHR 1.33, 95{\%} CI: 0.65–2.71). We found no difference in the long-term CRC risk between persons with negative colonoscopy after a positive FOBT screening test and the unscreened reference population (aHR 1.05, 95{\%} CI: 0.62–1.78). Since FOBT screen positive persons in our study remained at average risk of CRC despite of a negative index colonoscopy, we question the safety of suspending FOBT screening for this group. It needs to be monitored whether recent efforts to improve colonoscopy quality have been successful in ensuring low CRC risk after negative colonoscopy also in FOBT positive persons.",
keywords = "cancer epidemiology, colonoscopy, colorecal cancer, fobt, screening",
author = "Andreas Bjerrum and Ole Andersen and Anders Fischer and Jan Lindebjerg and Elsebeth Lynge",
year = "2017",
month = "8",
day = "1",
doi = "10.1002/ijc.30756",
language = "English",
volume = "141",
pages = "503--511",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "JohnWiley & Sons, Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort

AU - Bjerrum, Andreas

AU - Andersen, Ole

AU - Fischer, Anders

AU - Lindebjerg, Jan

AU - Lynge, Elsebeth

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Faecal occult blood test (FOBT) screening for colorectal cancer (CRC) is implemented in several countries. Approximately half of all screen positive persons have negative colonoscopy, but consensus is lacking on how these persons should be followed up. Health authorities in Denmark and The Netherlands recommend suspending screening for 8–10 years, while patients in UK are invited to screening after 2 years. In this cohort-study, we followed 166,277 individuals invited to FOBT-screening in 2005–2006 and a reference group comprising the remaining 1,240,348 Danes of the same age. We linked Danish population and health service registers to obtain information about colonoscopy outcome and incident CRC. We estimated CRC risk by colonoscopy outcome (adenoma, other colorectal pathology or negative colonoscopy) for the reference group, the screening group, and subgroups. Persons with positive screening FOBT followed by negative colonoscopy had the same long-term CRC risk as persons with adenoma detected due to a positive screening FOBT (aHR 1.33, 95% CI: 0.65–2.71). We found no difference in the long-term CRC risk between persons with negative colonoscopy after a positive FOBT screening test and the unscreened reference population (aHR 1.05, 95% CI: 0.62–1.78). Since FOBT screen positive persons in our study remained at average risk of CRC despite of a negative index colonoscopy, we question the safety of suspending FOBT screening for this group. It needs to be monitored whether recent efforts to improve colonoscopy quality have been successful in ensuring low CRC risk after negative colonoscopy also in FOBT positive persons.

AB - Faecal occult blood test (FOBT) screening for colorectal cancer (CRC) is implemented in several countries. Approximately half of all screen positive persons have negative colonoscopy, but consensus is lacking on how these persons should be followed up. Health authorities in Denmark and The Netherlands recommend suspending screening for 8–10 years, while patients in UK are invited to screening after 2 years. In this cohort-study, we followed 166,277 individuals invited to FOBT-screening in 2005–2006 and a reference group comprising the remaining 1,240,348 Danes of the same age. We linked Danish population and health service registers to obtain information about colonoscopy outcome and incident CRC. We estimated CRC risk by colonoscopy outcome (adenoma, other colorectal pathology or negative colonoscopy) for the reference group, the screening group, and subgroups. Persons with positive screening FOBT followed by negative colonoscopy had the same long-term CRC risk as persons with adenoma detected due to a positive screening FOBT (aHR 1.33, 95% CI: 0.65–2.71). We found no difference in the long-term CRC risk between persons with negative colonoscopy after a positive FOBT screening test and the unscreened reference population (aHR 1.05, 95% CI: 0.62–1.78). Since FOBT screen positive persons in our study remained at average risk of CRC despite of a negative index colonoscopy, we question the safety of suspending FOBT screening for this group. It needs to be monitored whether recent efforts to improve colonoscopy quality have been successful in ensuring low CRC risk after negative colonoscopy also in FOBT positive persons.

KW - cancer epidemiology

KW - colonoscopy

KW - colorecal cancer

KW - fobt

KW - screening

U2 - 10.1002/ijc.30756

DO - 10.1002/ijc.30756

M3 - Journal article

VL - 141

SP - 503

EP - 511

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -

ID: 189090443